We value your privacy

We use necessary cookies to make this site work, and Google Analytics to measure visits (it sets cookies and is not affected by the choices below). With your consent, we also use our own analytics cookies to understand how the site is used and improve it. Privacy policy

XOOBAY 数贝环球
金盒集团
金盒集团

金盒集团

Premier Elite

5
Products
0
Followers
2013
Established

Overseas listing in the US | China Securities Regulatory Commission issues supplementary document requirements for 2 companies listed in the US, including Zhengye Biologics and Longquan Haoma

Overseas listing in the US | China Securities Regulatory Commission issues supplementary document requirements for 2 companies listed in the US, including Zhengye Biologics and Longquan Haoma

Golden Box Group | Listing Guidance | US Listing |IPO|SPAC|RTO|US Listing | Professional US Listing Guidance Institution | US Stock Listing |

US Listing News Today's Quick View!

On January 12, 2024, the International Department issued supplementary material requirements to a total of 4 enterprises, among which Zhengye Biology and Longquan Haoma plan to list in the US.

Supplementary Material Requirements for Overseas Issuance and Listing Filing

(January 5, 2024 — January 11, 2024)

Below are the supplementary material requirements for enterprises planning to list in the US:

Zhengye Biology (filing notice issued) (plans to list on NASDAQ)

Please your company provide supplementary explanations on the following matters, and have a lawyer verify and issue clear legal opinions:

I. Regarding the equity structure, please explain: (1) The compliance of the equity control structure establishment, including but not limited to the specific circumstances of domestic natural persons and domestic institutions involved in the setup and round-trip investment fulfilling foreign exchange management, overseas investment and other regulatory procedures; (2) The tax payment status of Senhan Bio's acquisition of Zhengye Biology's shares; (3) The pricing basis, price fairness and tax payment status of Winsor Holding's acquisition of shares in Zhengye Animal Health.

II. Regarding the corporate governance and standardized operation status, please explain the current performance of the board of directors, independent directors, and secretary of the board, the setup status of the audit committee and other professional committees, as well as the company's standardized operation status.

US IPO Updates | Zhengye Bio-Tech, a veterinary vaccine enterprise from Jilin, US IPO Plans to List on NASDAQ

Longquan Haoma (filing notice obtained) (planned to be listed on NASDAQ)

Please supplement the following matters for your company, have the lawyer verify and issue a clear legal opinion:

I. Regarding the equity structure and equity changes, please explain: (1) The conclusive opinion on the fulfillment of regulatory procedures in foreign exchange management, foreign investment and other aspects involved in the establishment of the equity structure and round-trip M&A, and whether the reporting obligation stipulated in the "Measures for Foreign Investment Information Reporting" has been fulfilled; (2) The pricing basis, rationality and compliance with tax payment of the consideration of 0 yuan for the second, third and fourth equity transfers of Longquan Driving School; (3) The conclusive opinion on the legality and compliance of the equity changes of the main domestic operating entities on each occasion; (4) The equity structure after the completion of this issuance and listing, and whether the controlling shareholder and actual controller will change after this issuance.

II. Regarding the situation of invested and holding companies, please explain: (1) The reason and compliance of the unpaid registered capital of Longquan Driving School, the main domestic operating entity, and whether it has a major adverse impact on the company's business operation and solvency; (2) The amount of capital contribution, time of share acquisition, controlling party and other information of the important affiliated company Dazhong Aviation.

III. Regarding the corporate governance situation, please supplement the terms of office of the issuer's directors, supervisors and senior management, and the situation of the company's standardized operation.

Chinese concept stocks' US listings warm up,the approval process for overseas issuance and listing filings of enterpriseshas accelerated,2023 US stock market has strong gains,Chinese enterprises' confidence in listing in the US is also growing. Jinhe Group's Xiaojin will share hot information about US listings every day to help enterprises soar in listing!

尾图新.jpg

Disclaimer: Some information in this article is from the internet, the content of this article is for sharing purposes only. If there are any content and copyright issues, please contact us and we will handle it as soon as possible.

Originally published on 金盒企业管理集团